Effects of Curcumin in Combination with doxorubicin in Human Colorectal Cancer Cell Line

Azim Akbarzadeh Khiyavi

Abstract


Background: Colorectal cancer (CRC) is one of the main cancer related morbidity wordwidth. New therapeutic strategies are required for CRC. Anthracycline drugs such as doxorubicin (DOX) remain one of the most active wide-spectrum and cost-effective drugs in cancer therapy. However, colorectal cancer (CRC) cells are inherently resistant to anthracyclines. Curcumin, the active component and yellow pigment, has been considered as anti-cancer agents with anti-proliferation, anti-invasion, and anti-angiogenesis properties. Previous data show that curcumin may played main role as therapeutic agent for colorectal cancer. We aimed to assess the possible sensitizing effects of curcumin in HCT-116 CRC cells treated with DOX.

Methods;HCT-116 cells were treated with different doses of curcumin and DOX in increasing concentrations and cytotoxicity were evaluated after 48 h by Water Soluble Tetrazolium Salts(WST-1) method. In double combination treatments (48 h), the mentioned concentration were utilized;   D( Curcumin; 20 µM;DOX;5µM) C( Curcumin; 10 µM;DOX ;2.5µM ), B(Curcumin; 5 µM;DOX;1µM) and  A(Curcumin; 2.5 µM;DOX;0.5µM). 

Results; HCT-116 cells treatments with various concentrations of single agents (DOX and curcumin) decreased the cellular viability in a dose-dependent pattern. Here, we show that treatment of HCT-116 CRC cells with curcumin increases the efficacy of DOX-induced death in HTCT-116 cells. Curcumin treatments also results in higher cytotoxicity of DOX and the cell death percent in compared to higher doses in single treatments.

Conclusion; It could be concluded that Curcumin could acts as chemosensitiser towards the DOX therapy. So it might be used as adjuvant therapy to enhance DOX sensitivity in CRC cells.


Full Text:

PDF (FULL TEXT)

References


Comella P, Casaretti R, Sandomenico C, Avallone A, Franco L. Role of oxaliplatin in the treatment of colorectal cancer. Ther Clin Risk Manag. 2009;5(1):229-38.

Hsu HH, Chen MC, Baskaran R, Lin YM, Day CH, Lin YJ, Tu CC, Vijaya Padma V, Kuo WW, Huang CY. Oxaliplatin resistance in colorectal cancer cells is mediated via activation of ABCG2 to alleviate ER stress induced apoptosis. J Cell Physiol. 2018 Jul;233(7):5458-5467. doi: 10.1002/jcp.26406. Epub 2018 Jan 23.

Mohammadian M, Zeynali S, Azarbaijani AF, Khadem Ansari MH, Kheradmand F. Cytotoxic effects of the newly-developed chemotherapeutic agents 17-AAG in combination with oxaliplatin and capecitabine in colorectal cancer cell lines. Res Pharm Sci. 2017;12(6):517-525

Sonowal H, Pal PB, Wen JJ, Awasthi S, Ramana KV, Srivastava SK. Aldose reductase inhibitor increases doxorubicin-sensitivity of colon cancer cells and decreases cardiotoxicity. Sci Rep. 2017;7(1):3182. Published 2017 Jun 9. doi:10.1038/s41598-017-03284-w.

Chauhan DP.Chemotherapeutic potential of curcumin for colorectal cancer. Curr Pharm Des. 2002;8(19):1695-706.

Patel BB, Gupta D, Elliott AA, Sengupta V, Yu Y, Majumdar AP. Curcumin targets FOLFOX-surviving colon cancer cells via inhibition of EGFRs and IGF-1R. Anticancer Res. 2010;30(2):319-25.

Chauhan DP. Chemotherapeutic potential of curcumin for colorectal cancer. Curr Pharm Des. 2002;8:1695–1706.

Ebrahimi Far M, Nili-Ahmadabadi A, Akbarzadeh A, et al )2017.(8. Preparation, Characterization and Cytotoxic Effects of Pegylated Nanoliposomal Containing Carboplatin on Ovarian Cancer Cell Lines. Ind J Clin Biochem, 32, 230-234.

Izadi M, Ebrahimi Shahemabadi H, Kanaani L, et al )2016(. Investigation of characteristics of loaded carboplatin on the liposomal nanoparticles on the cell carcinoma of the human brain c6. Adv. Biores, 7, 113-118.

Poy D, Akbarzadeh A, Ebrahimi Shahmabadi H, et al)2016(10. Reparation, Characterization and Cytotoxic Effects of Liposomal Nanoparticles Containing Cisplatin: An in Vitro Study. Chemical Biology & Drug Design, 88, 568-573.

Poy D, Ebrahimi Shahemabadi H, Akbarzadeh A, et al )2018(11. Carboplatin liposomal nanoparticles: preparation, characterization and cytotoxicity effects on lung cancer in vitro environment. International Journal of Polymeric Materials and Polymeric Biomaterials, 67, 367-370.

Amiri B, Ebrahimi Far M, Saffari Z, et al )2016(12. Preparation, Characterization and Cytotoxicity of Silibinin Containing Nanoniosomes in T47D Human Breast Carcinoma Cells. Asian Pac J Cancer Prev, 17, 3833-3836.

Kanaani L, Javadi I, Ebrahimi Far M, Ebrahimi shahmabadi H, et al )2017(13. Effects of cisplatin-loaded niosomal nanoparticles on BT-20 human breast carcinoma cells. Asian Pac J Cancer Prev, 18, 365-368.

Mohamadi N, Mohammadian M, Toofani Milani A, et al (2017). Toxicity of cisplatin-loaded poly butyl cyanoacrylate nanoparticles in a brain cancer cell line: Anionic polymerization results. Asian Pac J Cancer Prev, 18, 629-32.

Zeynali M S, Mohammadian M, Kheradmand F et al (2018). A molecular basis for the synergy between 17 allylamino 17 demethoxy geldanamycin with Capecitabine and Irinotecan in human colorectal cancer cells through VEFG and MMP-9 gene expression. Gene. pii: S0378-1119(18)31050-3.

Arshad Z, Rezapour-Firouzi S, Mohammadian M, et al(2018).The Sources of Essential Fatty Acids for Allergic and Cancer Patients; a Connection with Insight into Mammalian Target of Rapamycin: A Narrative Review. Asian Pac J Cancer Prev. 19(9):2391-2401.

Ramasamy TS, Ayob AZ, Myint HH, Thiagarajah S, Amini F. Targeting colorectal cancer stem cells using curcumin and curcumin analogues: insights into the mechanism of the therapeutic efficacy. Cancer Cell Int. 2015;15:96. Published 2015 Oct 9. doi:10.1186/s12935-015-0241-x

Panda AK, Chakraborty D, Sarkar I, Khan T, Sa G. New insights into therapeutic activity and anticancer properties of curcumin. J Exp Pharmacol. 2017;9:31-45. Published 2017 Mar 31. doi:10.2147/JEP.S70568.

Meiyanto E, Putri DD, Susidarti RA, et al. Curcumin and its analogues (PGV-0 and PGV-1) enhance sensitivity of resistant MCF-7 cells to doxorubicin through inhibition of HER2 and NF-kB activation. Asian Pac J Cancer Prev. 2014;15(1):179–184.

Misra R, Sahoo SK. Coformulation of doxorubicin and curcumin in poly (D, L-lactide-co-glycolide) nanoparticles suppresses the development of multidrug resistance in K562 cells. Mol Pharm. 2011; 8(3):852–866.

Huang YF, Zhu DJ, Chen XW, et al. Curcumin enhances the effects of irinotecan on colorectal cancer cells through the generation of reactive oxygen species and activation of the endoplasmic reticulum stress pathway. Oncotarget. 2017;8(25):40264-40275.




DOI (PDF (FULL TEXT)): http://dx.doi.org/10.31557/APJCB.2018.3.4.89

Refbacks

  • There are currently no refbacks.


Copyright (c) 2019 Asian Pacific Journal of Cancer Biology

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.


 

  

PORTICO

 

Asia Pacific Organization for Cancer Prevention 

West Asia Organization for Cancer Prevention